Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Sanofi terminates option to license Ardelyx's RDX-002 program

Sep. 4, 2015

CSIR scientists describe PDE5A inhibitors

Aug. 21, 2015

FDA approves Procysbi for children aged 2-6 years with nephropathic cystinosis

Aug. 18, 2015

First patients randomized in phase IIa trial of SER-150 in diabetic nephropathy

Aug. 17, 2015

Proteon initiates second phase III study of vonapanitase

Aug. 17, 2015

Daiichi Sankyo discloses compounds for hyperphosphatemia

Aug. 13, 2015

Relypsa signs new patiromer agreements

Aug. 12, 2015

FDA accepts NDA for ZS-9 in hyperkalemia

July 30, 2015

Phase III extension studies show long-term benefit of NX-1207 in BPH

July 29, 2015

EMA committee recommends approval of Fexeric

July 27, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...